Christoffer Gebhardt: Can Anticoagulation Improve Outcomes in Melanoma Therapy?
Christoffer Gebhardt, Professor, Head of Skin Cancer Center and Vice Head of Department of Dermatology at The University Hospital Hamburg-Eppendorf, shared on LinkedIn:
”Antithrombotic therapies – particularly factor Xa inhibitors and anti-platelet agents – may limit melanoma metastasis and improve outcomes alongside established systemic treatments.
In patients receiving immune checkpoint inhibition (ICI), concomitant anticoagulation (AC) was associated with improved survival, while with targeted therapy (TT) concurrent AC enhanced both progression-free (PFS) and overall survival (OS).
Additionally, platelet inhibition with TT was linked to better OS after the first year.
These findings support the rationale for prospective clinical trials evaluating anticoagulation as a concomitant strategy in melanoma therapy.
Kudos to the first authors Julian Kött and Nina Matthes and all co-authors pushing translational research forward at the intersection of thrombosis and melanoma therapy!”
Title: Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence
Authors: Julian Kött, Nina Matthes, Alexander T Bauer, Noah Zimmermann, Tim Zell, Daniel J Smit, Stefan W Schneider, Christoffer Gebhardt
Read the Full Article on Journal for ImmunoTherapy of Cancer
Stay updated on all scientific advances with Hemostasis Today.
-
May 13, 2026, 17:38Rohit Sankar J. Snscphysio: Recognizing the Clot Before It Becomes Life-Threatening
-
May 13, 2026, 16:41Seema Dawood: When Elevated Platelets Signal a Myeloproliferative Neoplasm
-
May 13, 2026, 16:38Kari Tikkinen: Defining Thromboprophylaxis in MIBC Neoadjuvant Care
-
May 13, 2026, 16:28Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets
-
May 13, 2026, 15:58Aktham El-rekaby: Immunothrombosis in Acute Ischaemic Stroke
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding